Evaxion Biotech AS (EVAX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 0 | 0 | 0 | 0 | 507k | 51k | 154k | 3.02M |
Operating Income | -6.53M | -6.39M | -5.68M | -5.76M | -135.06M | -4.4M | -4.58M | -1.73M |
Pre Tax Income | -7.05M | -6.44M | -5.91M | -5.87M | -139.64M | 976k | -6.4M | -2.03M |
Net Income | -6.87M | -6.24M | -5.68M | -5.68M | -134.81M | 1.19M | -6.2M | -1.93M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -6.53M | -6.39M | -5.68M | -5.76M | -135.06M | -4.4M | -4.58M | -1.73M |
EBITDA | -5.87M | -6.39M | -5.68M | -5.76M | -130.84M | -4.4M | -4.58M | -1.73M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 507k |
Operating Income | -10.86M | -16.57M | -25.83M | -25.26M | -152.9M |
Pre Tax Income | -12.02M | -16.58M | -24.71M | -23.94M | -157.86M |
Net Income | -11.2M | -15.02M | -24.53M | -23.17M | -152.41M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.737 | -0.927 | -1.057 | -0.96 | -0.579 |
EBIT | -10.86M | -16.57M | -25.83M | -25.26M | -152.9M |
EBITDA | -10.78M | -16.46M | -25.49M | -24.61M | -148.67M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.